With the huge potential for biopharmaceuticals in China, international companies are eager to get into the Chinese market but concerns over IP, regulatory, GMP and quality standards, technical and scientific skills and capabilities are keeping them back.

On the other hand, Chinese companies interested in working with international companies or to enter the international markets, are equally constrained by the lack of technical know-how, the regulatory standards or the lack there-of, as well as need to source for the right partners and investors to help bring their skill-sets and business to the next level.

IBC's 2nd Annual BioProcess International™ China, scheduled for August 30-September 1, 2010, is aimed at addressing these industry trends, and to bring forth experts in the respective areas to help fill the knowledge gaps.